Navigation Links
"Scientific Oktoberfest" Draws the Worldwide Leading Researchers in the Field of Chemical Biology to Munich

MUNICH, September 9, 2011 /PRNewswire/ --

The "Scientific Oktoberfest" will be this year's meeting point for some of the internationally most distinguished researchers in the field of Chemical Biology. The so-called "CIPSM Fest of Chemical Biology" will be held from the 15th to the 16th of September in the Department of Chemistry of the Ludwig-Maximilians-Universität (LMU) München.

At the two-day conference, 400 researchers from around the world will discuss state-of-the art research in various fields spanning from chemistry to biology and present their latest results in the fight against diseases like cancer or bacterial infections.

Speakers will be:

  • Shankar Balasubramanian
    Dept. of Chemistry, University of Cambridge UK
    "Sequencing Nucleic Acids: A Passage from Chemistry to Science and Medicine"
  • Thomas Carell
    CIPSM at the Dept. of Chemistry, Ludwig-Maximilians-Universität (LMU) München
    "The chemistry of genome development"
  • Chris Chang
    Dept. of Chemistry, UC Berkeley
    "Molecular imaging approaches to understanding metal and redox biology in the brain"
  • Jon Clardy
    Dept. of Chemistry & Chemical Biology, Harvard Med. School, Broad Inst., Harvard University
    "Bacterial Conversations"
  • Benjamin F. Cravatt III
    Dept. of Chemical Physiology, The Skaggs Institute, The Scripps Research Institute
    "Activity-based proteomics: applications for enzyme and inhibitor discovery"
  • François Diederich
    ETH Zürich, Lab. of Organic Chemistry
    "Molecular Recognition at Enzyme Active Sites"
  • Wilfred A. van der Donk
    Dept. of Chemistry, University of Illinois at Urba na-Champaign
    "Posttranslational modifications in natural product biosynthesis"
  • Michael Famulok
    Rheinische Friedrich-Wilhelms-Universität Bonn, Lab. of Chemical Biology
    "Insight into ErbB receptor signaling from a Chemical Biology perspective"
  • Itaru Hamachi
    Dept. of Synthetic Chemistry and Biological Chemistry, Kyoto University
    "Protein labeling and engineering in live cell systems"
  • Julius Rebek
    The Skaggs Institute for Chemical Biology, The Scripps La Jolla
    "Molecular Behavior in Small Spaces"
  • Peter G. Schultz
    The Scripps Research Institute, La Jolla
    "Synthesis at the Interface of Chemistry and Biology"
  • Mitsuhiko Shionoya
    Dept. of Chemistry, University of Tokyo
    "Bio-inspired Molecular Design of Supramolecular Architectures"
  • Hiroshi Sugiyama
    Dept. of Chemistry, Kyoto University
    "Chemical Biology that Controls DNA Structure and Function"
  • Christopher T. Walsh
    Harvard Medical School, Dept. of Chemistry & Chemical Biology, Harvard University
    "Thiazole Peptide Antibiotic Biosynthesis: A Cascade of Posttranslational Modifications"

For more information please visit

Dr. Oliver Baron
Managing Director of the
Center For Integrated Protein Science Munich (CIPSM) at Ludwig-Maximilians-Universität (LMU) München
Department of Chemistry
81377 Munich
Tel: +49(0)89-2180-77880

SOURCE Center For Integrated Protein Science Munich (CIPSM)
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain
2. Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)
3. Cimzia Draws Even With Simponi at Six Months Post Launch According to Recent BioTrends Survey
4. China Medicine Corporation Voluntarily Withdraws Application for Nasdaq Listing
5. Centocor Ortho Biotech Products, L.P. Voluntarily Withdraws NDA for Trabectedin
6. A Worldwide Phase III Clinical Trial Seeks U.S. Patients to Explore Investigational Drug Phenoxodiol
7. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
8. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
9. Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies
10. Orion Genomics Gains Exclusive Worldwide Rights to the IGF2 Gene for Colorectal Cancer Risk Testing Through Licensing Agreement With Johns Hopkins University
11. BBK Worldwide Celebrates 25th Anniversary of Industry Leadership Through Innovation in Patient Enrollment
Post Your Comments:
(Date:11/26/2015)... 2015 ) ... "Radioimmunoassay Market by Type (Reagents & Kits, ... Clinical Diagnostic Labs), Application (Research, Clinical Diagnostics), ... report to their offering. --> ... of the "Radioimmunoassay Market by Type ...
(Date:11/25/2015)... 2015 ... "Global Brain Monitoring Devices Market 2015-2019" ... ) has announced the addition ... Market 2015-2019" report to their offering. ... ) has announced the addition of ...
(Date:11/25/2015)... THOUSAND OAKS, Calif. , Nov. 25, 2015 /PRNewswire/ ... of a Biologics License Application (BLA) with ... Administration (FDA) for ABP 501, a biosimilar candidate to ... the first adalimumab biosimilar application submitted to the FDA ... biosimilar pathway. Sean E. Harper , M.D., ...
Breaking Medicine Technology:
(Date:11/29/2015)... ... ... Effective immediately, every single IguanaMed scrub style will be available at Target via ... “Buy One Scrub Set, Get the 2nd Scrub Set 50% Off” for a limited ... price. , IguanaMed’s mission is to outfit every healer around the world ...
(Date:11/28/2015)... , ... November 28, 2015 , ... Safe storage for ... of two inventors, one from Lakewood, New Jersey and the other from Bradley Beach, ... patent-pending PROTECTOR to save the expense of having to replace NuvaRings more often than ...
(Date:11/28/2015)... ... November 28, 2015 , ... Pixel Film Studios is back again ... choose from, the possibilities are endless. Users have full control over angle of view, ... masking effects, users are sure to get heads to turn. , ProPanel: Pulse offers ...
(Date:11/27/2015)... ... 27, 2015 , ... According to an article published November 6th ... the University of British Columbia suggested that laws requiring bicyclists to wear helmets may ... part of the reason for the controversial conclusion is that, while helmets have certainly ...
(Date:11/27/2015)... , ... November 27, 2015 , ... A team of ... ways to treat it. Surviving Mesothelioma has just posted the findings on the website. ... Hospital Zurich analyzed the cases of 136 mesothelioma patients who were treated with chemotherapy ...
Breaking Medicine News(10 mins):